A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Ovarian CancerCancer of the Fallopian TubePeritoneal Cancer
Interventions
DRUG
ZD1839
DRUG
tamoxifen
Trial Locations (1)
40217
Dept. of Gynecology, Evangelisches Krankenhaus, Düsseldorf
All Listed Sponsors
lead
AGO Study Group
OTHER
NCT00189358 - A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy | Biotech Hunter | Biotech Hunter